![BIGBEAR Pharmaceutical объявляет об одобрении биниметиниба[Binimetinib] и энкорафениба[Encorafenib] в Лаосе](https://lienteh.net/wp-content/uploads/2024/10/2024-10-1274-150x150.webp "BIGBEAR Pharmaceutical объявляет об одобрении биниметиниба[Binimetinib] и энкорафениба[Encorafenib] в Лаосе")
Vientiane, Laos - October 12 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treatments, today announced that Binimetinib…
Read More
Vientiane, Laos - September 20, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treatments, today announced that…
Read More
Вьентьян, Лаос - 12 октября 2024 г. - BigBear Pharma, ведущая биофармацевтическая компания, занимающаяся разработкой и коммерциализацией инновационных методов лечения рака, сегодня объявила, что…
Read MoreIntroduction If you are looking for new business opportunities in the pharmaceutical industry, there is a product for you: Generic Mitotane sold under the brand…
Read More
Вьентьян, Лаос – 8 апреля 2024 г. – BigBear Pharma, ведущая биофармацевтическая компания, занимающаяся разработкой и коммерциализацией инновационных методов лечения рака, сегодня объявила, что…
Read More
О препарате Aumolertinib Aumolertinib (ранее известный как almonertinib) — это ингибитор тирозинкиназы EGFR, нацеленный на сенсибилизирующие мутации EGFR…
Acerca de Aumolertinib Aumolertinib (anteriormente conocido como almonertinib) es un inhibidor de la tirosina quinasa del EGFR que…
Tunlametinib (HL-085) is an oral, selective, mitogen-activated protein kinase kinase 1 and 2 (MEK 1/2) inhibitor, for…
About Disitamab Vedotin An antibody-drug conjugate (ADC) composed of trastuzumab, a humanized immunoglobulin G1 (IgG1) monoclonal…
About Anlotinib Anlotinib is a orally administered tyrosine kinase inhibitor that targets vascular endothelial growth factor…
Entinostat is a synthetic drug that inhibits histone deacetylase (HDAC) enzymes. Entinostat sold as brand name 景助达® …
Surufatinib is a novel, oral angio-immuno kinase inhibitor that selectively inhibits the tyrosine kinase activity associated…
About Iparomlimab/Tuvonralimab A mixture of the two engineered monoclonal antibodies iparomlimab, which is an immunoglobulin G4…
Pamiparib (BGB-290) is a drug used to treat various types of cancer. It's a PARP inhibitor,…
Socazolimab is a fully human anti-PD-L1 (programmed cell death 1 ligand 1) monoclonal antibody, an immune checkpoint…
Copyright © 2021-2022 LienTeh.net All rights reserved.
